{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:42:59Z","timestamp":1794440579328,"version":"4.9.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1136\/ijgc-2020-001784","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T05:20:44Z","timestamp":1614576044000},"page":"399-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Fertility and pregnancy outcome in gestational trophoblastic disease"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-0738","authenticated-orcid":false,"given":"Ulrika","family":"Joneborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonoor","family":"Coopmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"van Trommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Seckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christianne A R","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001784_bb0010","article-title":"Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24 Suppl 6","author":"Seckl","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ygyno.2019.07.024","article-title":"When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): a national analysis on over 4,000 patients","volume":"155","author":"Balachandran","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajog.2010.06.073","article-title":"Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole","volume":"203","author":"Lurain","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001784_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0020-7292(02)00063-2","article-title":"FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee","volume":"77","author":"FIGO Oncology Committee","year":"2002","journal-title":"Int J Gynecol Obstet"},{"key":"10.1136\/ijgc-2020-001784_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.hoc.2011.10.007","article-title":"Current management of gestational trophoblastic neoplasia","volume":"26","author":"Goldstein","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1136\/ijgc-2020-001784_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2016.08.330","article-title":"15 years of progress in gestational trophoblastic disease: scoring, standardization, and salvage","volume":"144","author":"Brown","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0040","first-page":"47","article-title":"Psychologic impact of follow-up after low-risk gestational trophoblastic disease","volume":"56","author":"Lok","year":"2011","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0045","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1521-6934(03)00093-2","article-title":"Psychosocial and reproductive outcomes of gestational trophoblastic diseases","volume":"17","author":"Garner","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1136\/ijgc-2020-001784_bb0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1471-0528.2003.02419.x","article-title":"Pregnancy after EMA\/CO for gestational trophoblastic disease: a report from the Netherlands","volume":"110","author":"Lok","year":"2003","journal-title":"BJOG: An Internal Journal of Obs Gyn"},{"key":"10.1136\/ijgc-2020-001784_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/REP-12-0121","article-title":"What lies behind chemotherapy-induced ovarian toxicity?","volume":"144","author":"Ben-Aharon","year":"2012","journal-title":"Reproduction"},{"key":"10.1136\/ijgc-2020-001784_bb0060","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Loren","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0065","first-page":"678","article-title":"Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding)","volume":"27","author":"Mart\u00ednez Lopez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ijgc-2020-001784_bb0070","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10815-016-0683-7","article-title":"Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes","volume":"33","author":"Boots","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"10.1136\/ijgc-2020-001784_bb0075","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0277-5379(86)90083-0","article-title":"Fertility in patients with gestational trophoblastic tumors treated with etoposide","volume":"22","author":"Adewole","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dmz027","article-title":"Ovarian damage from chemotherapy and current approaches to its protection","volume":"25","author":"Spears","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1136\/ijgc-2020-001784_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/gyno.1998.5167","article-title":"Subsequent reproductive experience after treatment for gestational trophoblastic disease","volume":"71","author":"Kim","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0090","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/humrep\/16.6.1274","article-title":"Subsequent pregnancy outcome in patients with spontaneous resolution of hCG after evacuation of hydatidiform mole: comparison between complete and partial mole","volume":"16","author":"Matsui","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1136\/ijgc-2020-001784_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1471-0528.2003.02388.x","article-title":"Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy","volume":"110","author":"Sebire","year":"2003","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001784_bb0100","doi-asserted-by":"crossref","first-page":"681.e1","DOI":"10.1016\/j.ajog.2014.06.030","article-title":"Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study","volume":"211","author":"Joneborg","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001784_bb0105","first-page":"188","article-title":"Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center","volume":"59","author":"Vargas","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0110","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/humrep\/dev169","article-title":"Risk of recurrent molar pregnancies following complete and partial hydatidiform moles","volume":"30","author":"Eagles","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1136\/ijgc-2020-001784_bb0115","first-page":"81","article-title":"Subsequent pregnancy outcome, including repeat molar pregnancy","volume":"43","author":"Berkowitz","year":"1998","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0120","first-page":"595","article-title":"Familial recurrent hydatidiform mole: a review","volume":"49","author":"Fisher","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s004399900088","article-title":"A familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution","volume":"105","author":"Helwani","year":"1999","journal-title":"Hum Genet"},{"key":"10.1136\/ijgc-2020-001784_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13669-013-0076-1","article-title":"Genetics and epigenetics of recurrent hydatidiform moles: basic science and genetic counselling","volume":"3","author":"Nguyen","year":"2014","journal-title":"Curr Obstet Gynecol Rep"},{"key":"10.1136\/ijgc-2020-001784_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(11)61751-0","article-title":"What a difference an egg makes","volume":"378","author":"Fisher","year":"2011","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001784_bb0140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/IGC.0000000000000903","article-title":"Role of surgery in the management of hydatidiform mole in elderly patients: a single-center clinical experience","volume":"27","author":"Giorgione","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ijgc-00009577-200301000-00018","article-title":"Transcatheter angiographic embolization for the control of massive pelvic hemorrhage due to gestational trophoblastic disease: a case series and review of the literature","volume":"13","author":"Moodley","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/806256","article-title":"Current chemotherapeutic management of patients with gestational trophoblastic neoplasia","volume":"2011","author":"May","year":"2011","journal-title":"Chemother Res Pract"},{"key":"10.1136\/ijgc-2020-001784_bb0155","article-title":"First-line chemotherapy in low-risk gestational trophoblastic neoplasia","volume":"19","author":"Lawrie","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1136\/ijgc-2020-001784_bb0160","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/IGC.0000000000001175","article-title":"Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: retrospective analysis from the MITO-9 group","volume":"28","author":"Cioffi","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0165","first-page":"204","article-title":"Reproductive outcomes after multiagent chemotherapy for high-risk gestational trophoblastic neoplasia","volume":"59","author":"Wong","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0170","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1200\/JCO.2014.57.5332","article-title":"Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause","volume":"33","author":"Savage","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijgo.2008.05.013","article-title":"Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia","volume":"103","author":"Yarandi","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2020-001784_bb0180","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1471-0528.1998.tb10271.x","article-title":"Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome","volume":"105","author":"Woolas","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1136\/ijgc-2020-001784_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.bjc.6600041","article-title":"The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours","volume":"86","author":"Blagden","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0190","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/sj.bjc.6601422","article-title":"Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects","volume":"89","author":"Khan","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0090-8258(02)00071-9","article-title":"Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor","volume":"88","author":"Matsui","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ygyno.2004.02.018","article-title":"Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births","volume":"93","author":"Goto","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0205","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/ijgc-2019-000604","article-title":"Gestational trophoblastic neoplasia: a meta-analysis evaluating reproductive and obstetrical outcomes after administration of chemotherapy","volume":"29","author":"Tranoulis","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2008.10.027","article-title":"Maternal and perinatal outcomes of first pregnancy after chemotherapy for gestational trophoblastic neoplasia in Brazilian women","volume":"112","author":"Braga","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0215","first-page":"531","article-title":"Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor","volume":"49","author":"Matsui","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2005.06.032","article-title":"The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey","volume":"99","author":"van Trommel","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AOG.0000000000001554","article-title":"Second curettage for low-risk nonmetastatic gestational trophoblastic neoplasia","volume":"128","author":"Osborne","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001784_bb0230","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ygyno.2017.03.018","article-title":"The added value of hysterectomy in the management of gestational trophoblastic neoplasia","volume":"145","author":"Eysbouts","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1136\/ijgc-2020-001784_bb0240","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0245","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2003.08.028","article-title":"Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy\u2606","volume":"91","author":"Escobar","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0250","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/ijgc-00009577-200605000-00074","article-title":"Results with EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia","volume":"16","author":"Turan","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0255","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1525-1438.2007.00999.x","article-title":"EMA-CO chemotherapy for high-risk gestational trophoblastic neoplasia: a clinical analysis of 54 patients","volume":"18","author":"Lu","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1471-0528.2003.00039.x","article-title":"Feasibility of central co-ordinated EMA\/CO for gestational trophoblastic disease in the Netherlands","volume":"111","author":"van der Houwen","year":"2004","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001784_bb0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejca.2018.12.033","article-title":"The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia","volume":"109","author":"Frijstein","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0270","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001784_bb0275","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/OGX.0b013e31829a82df","article-title":"The role of surgery in the management of gestational trophoblastic neoplasia","volume":"68","author":"Doll","year":"2013","journal-title":"Obstet Gynecol Surv"},{"key":"10.1136\/ijgc-2020-001784_bb0280","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/1097-0142(197602)37:2+<1043::AID-CNCR2820370809>3.0.CO;2-N","article-title":"Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms","volume":"37","author":"Ross","year":"1976","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0285","first-page":"248","article-title":"Effect of early pregnancy following chemotherapy on disease relapse and fetal outcome in women treated for gestational trophoblastic neoplasia","volume":"59","author":"Williams","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0290","first-page":"380","article-title":"Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor","volume":"47","author":"Garner","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0295","first-page":"181","article-title":"[Analysis of pregnancy outcome after chemotherapy of trophoblastic disease]","volume":"38","author":"Kobayashi","year":"1986","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"10.1136\/ijgc-2020-001784_bb0300","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0959-8049(98)00059-8","article-title":"Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years","volume":"34","author":"Bower","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0305","first-page":"104","article-title":"Reproductive status in GTD treated with etoposide","volume":"42","author":"Matsui","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0310","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.ejca.2014.05.002","article-title":"Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia","volume":"50","author":"Even","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0315","first-page":"177","article-title":"The outcome of pregnancy after chemotherapy for gestational trophoblastic disease","volume":"6","author":"Hsieh","year":"1985","journal-title":"Biol Res Pregnancy Perinatol"},{"key":"10.1136\/ijgc-2020-001784_bb0320","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0002-9378(88)90021-X","article-title":"Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up","volume":"158","author":"Song","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001784_bb0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/00016348809004160","article-title":"Reproductive performance of patients with gestational trophoblastic disease in Hong Kong","volume":"67","author":"Ngan","year":"1988","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1136\/ijgc-2020-001784_bb0330","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-0528.1990.tb02551.x","article-title":"Malignant trophoblastic tumours in Norway. fertility rate after chemotherapy","volume":"97","author":"KJER","year":"1990","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001784_bb0335","first-page":"522","article-title":"Pregnancy after chemotherapy for gestational trophoblastic disease","volume":"35","author":"Ayhan","year":"1990","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0340","first-page":"146","article-title":"Return of fertility after successful chemotherapy treatment of gestational trophoblastic tumors","volume":"44","author":"Amr","year":"1999","journal-title":"Int J Fertil Womens Med"},{"key":"10.1136\/ijgc-2020-001784_bb0345","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/bmj.288.6411.103","article-title":"Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours","volume":"288","author":"Rustin","year":"1984","journal-title":"BMJ"},{"key":"10.1136\/ijgc-2020-001784_bb0350","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/1806-9282.62.09.837","article-title":"Pregnancy outcomes after chemotherapy for trophoblastic neoplasia","volume":"62","author":"Garcia","year":"2016","journal-title":"Rev Assoc Med Bras"},{"key":"10.1136\/ijgc-2020-001784_bb0355","first-page":"1004","article-title":"Pregnancy outcome of patients conceiving within one year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 cases","volume":"111","author":"Zhu","year":"1998","journal-title":"Chin Med J"},{"key":"10.1136\/ijgc-2020-001784_bb0360","first-page":"274","article-title":"Fertility-sparing partial hysterectomy for gestational trophoblastic neoplasia: an analysis of 36 cases","volume":"59","author":"Cheng","year":"2014","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00555","article-title":"Gonadal failure is common in long-term survivors of childhood high-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell rescue","volume":"10","author":"Utriainen","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1136\/ijgc-2020-001784_bb0370","first-page":"4451","article-title":"Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis","volume":"27","author":"Gerstl","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0375","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.20.00803","article-title":"Avelumab in patients with gestational trophoblastic tumors with resistance to single-agent chemotherapy: cohort a of the TROPHIMMUN phase II trial","volume":"38","author":"You","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0380","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.annonc.2020.02.015","article-title":"Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy","author":"Bolze","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0385","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ygyno.2019.03.011","article-title":"Placental site trophoblastic tumor and epithelioid trophoblastic tumor: clinical and pathological features, prognostic variables and treatment strategy","volume":"153","author":"Gadducci","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0390","author":"Kurman","year":"2002"},{"key":"10.1136\/ijgc-2020-001784_bb0395","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0140-6736(09)60618-8","article-title":"Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study","volume":"374","author":"Schmid","year":"2009","journal-title":"The Lancet"},{"key":"10.1136\/ijgc-2020-001784_bb0400","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2016.05.006","article-title":"Placental site trophoblastic tumor: a review of 108 cases and their implications for prognosis and treatment","volume":"142","author":"Zhao","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0405","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ejca.2015.05.026","article-title":"Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases","volume":"51","author":"Bolze","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0410","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ygyno.2018.11.015","article-title":"Management and prognostic factors of epithelioid trophoblastic tumors: results from the International Society for the Study of Trophoblastic Diseases database","volume":"152","author":"Frijstein","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0415","first-page":"224","article-title":"Long-term outcome of placental site trophoblastic tumor in the Netherlands","volume":"58","author":"van Trommel","year":"2013","journal-title":"The Journal of reproductive medicine"},{"key":"10.1136\/ijgc-2020-001784_bb0420","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/IGC.0b013e31829ea023","article-title":"Epithelioid trophoblastic tumor: an outcome-based literature review of 78 reported cases","volume":"23","author":"Zhang","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0425","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-017-0502-0","article-title":"Fertility sparing strategies in patients affected by placental site trophoblastic tumor","volume":"18","author":"Chiofalo","year":"2017","journal-title":"Curr Treat Options Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0430","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/IGC.0b013e31824a1bd6","article-title":"Fertility-preserving treatment in young patients with placental site trophoblastic tumors","volume":"22","author":"Shen","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001784_bb0435","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0029-7844(96)00124-X","article-title":"Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction","volume":"88","author":"Leiserowitz","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001784_bb0440","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2004.08.049","article-title":"Placental site trophoblastic tumor: outcome of five cases including fertility preserving management","volume":"96","author":"Machtinger","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0445","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-0528.2011.03230.x","article-title":"Placental site trophoblastic tumours and the concept of fertility preservation","volume":"119","author":"Saso","year":"2012","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001784_bb0450","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1470-2045(07)70243-7","article-title":"Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour","volume":"8","author":"Pfeffer","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0455","first-page":"475","article-title":"Attempted conservative management of a placental site trophoblastic tumor: a case report","volume":"78","author":"Ashton","year":"2014","journal-title":"Conn Med"},{"key":"10.1136\/ijgc-2020-001784_bb0460","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ygyno.2006.07.039","article-title":"Fertility sparing therapy in a patient with placental site trophoblastic tumor: a case report","volume":"103","author":"Numnum","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001784_bb0465","first-page":"585","article-title":"Placental site trophoblastic tumor: an overview","volume":"49","author":"Bonazzi","year":"2004","journal-title":"J Reprod Med"},{"key":"10.1136\/ijgc-2020-001784_bb0470","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0b013e31826d7da6","article-title":"Unsuccessful planned conservative resection of placental site trophoblastic tumor","volume":"121","author":"Taylor","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001784_bb0475","article-title":"Placental site trophoblastic tumor: successful treatment of 13 cases","volume":"32","author":"Alexander","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2020-001784_bb0480","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00404-018-05037-0","article-title":"Intermediate trophoblastic tumor: the clinical analysis of 62 cases and prognostic factors","volume":"299","author":"Zhang","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2020-001784_bb0485","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijgo.2015.01.006","article-title":"Curative surgery for placental site trophoblastic tumors","volume":"130","author":"Renaud","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2020-001784_bb0490","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ajcp\/aqy039","article-title":"A case series of five patients with pure or mixed gestational epithelioid trophoblastic tumors and a literature review on mixed tumors","volume":"150","author":"Tse","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"10.1136\/ijgc-2020-001784_bb0495","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gore.2015.10.002","article-title":"Choriocarcinoma coexisting with epithelioid trophoblastic tumor of the uterine horn","volume":"14","author":"Imamura","year":"2015","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2020-001784_bb0500","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/PGP.0000000000000128","article-title":"Atypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a clinicopathologic study of 21 cases","volume":"34","author":"Kaur","year":"2015","journal-title":"Int J Gynecol Pathol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24020279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24020279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:53Z","timestamp":1753223933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24020279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1048891X24020279"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001784","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/ijgc-2020-001784.supp1","asserted-by":"subject"}]},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility and pregnancy outcome in gestational trophoblastic disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}